Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BiActive Detox is a multi-ingredient dietary supplement developed by Astrapharm. It is formulated to provide comprehensive support for body detoxification and protection against oxidative stress. The supplement contains a synergistic blend of four active ingredients: L-glutathione (250 mg), N-acetylcysteine (200 mg), ascorbic acid (vitamin C, 210 mg), and glycine (200 mg). L-glutathione acts as a primary antioxidant to protect cells from damage, while N-acetylcysteine and glycine serve as essential precursors for the body's endogenous synthesis of glutathione. Ascorbic acid further enhances the antioxidant profile and supports immune function. BiActive Detox is administered orally in sachet form and is indicated for general detoxification, particularly following medication overload or stress affecting the liver, gastrointestinal tract, or immune system. It was approved and launched in 2025.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BiActive Detox.